Skip to search formSkip to main contentSkip to account menu

LY2510924

Known as: CXCR4 Peptide Antagonist LY2510924 
An inhibitor of CXC chemokine receptor 4 (CXCR4), with potential antineoplastic activity. Upon subcutaneous administration, CXCR4 inhibitor LY2510924… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.